Defendant Name:
Aegerion Pharmaceuticals, Inc.
Defendant Type:
Subsidiary of Public Company
Public Company Parent:
Novelion Therapeutics Inc.
SIC Code:
2834
CUSIP:
67001K20
Document Reference:
court-doc5_17-cv-11817
Document Details
Legal Case Name
SEC v. Aegerion Pharmaceuticals, Inc.
Document Name
Final Judgment as to Defendant Aegerion Pharmaceuticals, Inc.
Document Date
25-Sep-2017
Document Format
Civil Proceeding
Case Number
17-cv-11817
Federal District Court
Massachusetts, District of Massachusetts
Federal District Judge
William Young
Allegation Type
Issuer Reporting and Disclosure
Document Summary
On September 25, 2017, a final judgement was entered in this case.
Disgorgement & Penalty Information
Monetary Penalties:
Civil Penalty
Individual:
$4,100,000.00
Shared: